Using the Kaplan–Meier plotter database (KMplotter)28, we found that high Gas6 mRNA correlated to improved RFS in breast cancer patients, particularly in patients with luminal A breast cancer, when stratified with those who had received therapy (Fig. 4b). Here, GAS6 is linked to breast carcinoma.